Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 49 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Alpha-1 antitrypsin for treating high risk, acute graft versus host disease in people aged ≥ 12 years	Alpha-1 antitrypsin	Graft versus host disease (GvHD)	Immunology	2024	View \| Download
BI 1015550 for treating idiopathic pulmonary fibrosis or progressive pulmonary fibrosis	BI 1015550	Idiopathic pulmonary fibrosis , Progressive pulmonary fibrosis	Respiratory System	2024	View \| Download
Blinatumomab with chemotherapy for frontline consolidation treatment of Philadelphia chromosome negative, measurable residual disease negative, B-lineage acute lymphoblastic leukaemia	Blinatumomab (Blincyto) , Chemotherapy	Acute lymphoblastic leukaemia (ALL)	Haematological Cancer and Lymphomas	2024	View \| Download
Brensocatib for people aged 12 and over with non-cystic fibrosis bronchiectasis	Brensocatib (AZD-7986)	Bronchiectasis	Respiratory System	2024	View \| Download
Brentuximab vedotin with chemotherapy (BrECADD) for previously untreated advanced classical Hodgkin lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , Chemotherapy	Hodgkin lymphoma	Haematological Cancer and Lymphomas	2024	View \| Download
Brentuximab vedotin with cyclophosphamide, prednisone and doxorubicin for treating peripheral Tcell lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , Cyclophosphamide (Procytox; cyclophosphamide monohydrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Prednisone (Decadron; Lodotra)	Peripheral T-cell lymphoma (PTCL)	Haematological Cancer and Lymphomas	2024	View \| Download
Budesonide-glycopyrronium-formoterol fumarate for the treatment of severe and inadequately controlled asthma	Budesonide-glycopyrronium-formoterol fumarate	Asthma	Respiratory System	2024	View \| Download
Cefepime-enmetazobactam for treating hospital-acquired pneumonia including ventilator-associated pneumonia	Exblifep (Cefepime;Enmetazobactam)	Hospital-acquired pneumonia , Ventilator-associated pneumonia	Infectious Disease , Respiratory System	2024	View \| Download
Darolutamide with androgen deprivation therapy for metastatic hormone sensitive prostate cancer	Darolutamide (ODM-201; BAY-1841788; Nubeqa)	Prostate cancer	Male Reproductive Cancer	2024	View \| Download
Datopotamab deruxtecan for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer	Datopotamab deruxtecan (DS-1062)	Breast cancer	Breast Cancer	2024	View \| Download